The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Glucose Monitoring-Global Market Insights and Sales Trends 2024
Synopsis
One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.
The global Blood Glucose Monitoring market size is expected to reach US$ 10610 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Glucose Monitoring in various end use industries. The expanding demands from the Hospitals Diagnostic Centers, Home Settings and Clinics,, are propelling Blood Glucose Monitoring market. Single Point Blood Glucose Meters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Continuous Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Glucose Monitoring, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Glucose Monitoring market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Glucose Monitoring market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Glucose Monitoring sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Glucose Monitoring covered in this report include Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Nipro Diagnostics, Inc. and Terumo Medical Corporation, etc.
The global Blood Glucose Monitoring market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Global Blood Glucose Monitoring market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Glucose Monitoring market, Segment by Type:
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Global Blood Glucose Monitoring market, by Application
Hospitals Diagnostic Centers
Home Settings
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Glucose Monitoring companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
One of the main aims of diabetes treatment is to keep blood glucose levels within a specified target range. The key is balancing your food with your activity, lifestyle and diabetes medicines. Blood glucose monitoring can help you understand the link between blood glucose, food, exercise and insulin.
The global Blood Glucose Monitoring market size is expected to reach US$ 10610 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Glucose Monitoring in various end use industries. The expanding demands from the Hospitals Diagnostic Centers, Home Settings and Clinics,, are propelling Blood Glucose Monitoring market. Single Point Blood Glucose Meters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Continuous Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Glucose Monitoring, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Glucose Monitoring market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Glucose Monitoring market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Glucose Monitoring sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Glucose Monitoring covered in this report include Abbott Laboratories, ARKRAY, Inc., Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Nipro Diagnostics, Inc. and Terumo Medical Corporation, etc.
The global Blood Glucose Monitoring market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
ARKRAY, Inc.
Bayer AG
Dexcom, Inc.
F. Hoffmann-La Roche Ltd
Johnson & Johnson
Medtronic plc
Nipro Diagnostics, Inc.
Terumo Medical Corporation
Global Blood Glucose Monitoring market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Glucose Monitoring market, Segment by Type:
Single Point Blood Glucose Meters
Continuous Glucose Monitoring Systems
Global Blood Glucose Monitoring market, by Application
Hospitals Diagnostic Centers
Home Settings
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Glucose Monitoring companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Blood Glucose Monitoring
1.1 Blood Glucose Monitoring Market Overview
1.1.1 Blood Glucose Monitoring Product Scope
1.1.2 Blood Glucose Monitoring Market Status and Outlook
1.2 Global Blood Glucose Monitoring Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Blood Glucose Monitoring Market Size by Region (2018-2029)
1.4 Global Blood Glucose Monitoring Historic Market Size by Region (2018-2023)
1.5 Global Blood Glucose Monitoring Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Blood Glucose Monitoring Market Size (2018-2029)
1.6.1 North America Blood Glucose Monitoring Market Size (2018-2029)
1.6.2 Europe Blood Glucose Monitoring Market Size (2018-2029)
1.6.3 Asia-Pacific Blood Glucose Monitoring Market Size (2018-2029)
1.6.4 Latin America Blood Glucose Monitoring Market Size (2018-2029)
1.6.5 Middle East & Africa Blood Glucose Monitoring Market Size (2018-2029)
2 Blood Glucose Monitoring Market by Type
2.1 Introduction
2.1.1 Single Point Blood Glucose Meters
2.1.2 Continuous Glucose Monitoring Systems
2.2 Global Blood Glucose Monitoring Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Blood Glucose Monitoring Historic Market Size by Type (2018-2023)
2.2.2 Global Blood Glucose Monitoring Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Blood Glucose Monitoring Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Blood Glucose Monitoring Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Blood Glucose Monitoring Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Blood Glucose Monitoring Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Blood Glucose Monitoring Revenue Breakdown by Type (2018-2029)
3 Blood Glucose Monitoring Market Overview by Application
3.1 Introduction
3.1.1 Hospitals Diagnostic Centers
3.1.2 Home Settings
3.1.3 Clinics
3.2 Global Blood Glucose Monitoring Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Blood Glucose Monitoring Historic Market Size by Application (2018-2023)
3.2.2 Global Blood Glucose Monitoring Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Blood Glucose Monitoring Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Blood Glucose Monitoring Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Blood Glucose Monitoring Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Blood Glucose Monitoring Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Blood Glucose Monitoring Revenue Breakdown by Application (2018-2029)
4 Blood Glucose Monitoring Competition Analysis by Players
4.1 Global Blood Glucose Monitoring Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Monitoring as of 2022)
4.3 Date of Key Players Enter into Blood Glucose Monitoring Market
4.4 Global Top Players Blood Glucose Monitoring Headquarters and Area Served
4.5 Key Players Blood Glucose Monitoring Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Glucose Monitoring Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Blood Glucose Monitoring Products, Services and Solutions
5.1.4 Abbott Laboratories Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 ARKRAY, Inc.
5.2.1 ARKRAY, Inc. Profile
5.2.2 ARKRAY, Inc. Main Business
5.2.3 ARKRAY, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.2.4 ARKRAY, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.2.5 ARKRAY, Inc. Recent Developments
5.3 Bayer AG
5.3.1 Bayer AG Profile
5.3.2 Bayer AG Main Business
5.3.3 Bayer AG Blood Glucose Monitoring Products, Services and Solutions
5.3.4 Bayer AG Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.3.5 Dexcom, Inc. Recent Developments
5.4 Dexcom, Inc.
5.4.1 Dexcom, Inc. Profile
5.4.2 Dexcom, Inc. Main Business
5.4.3 Dexcom, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.4.4 Dexcom, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.4.5 Dexcom, Inc. Recent Developments
5.5 F. Hoffmann-La Roche Ltd
5.5.1 F. Hoffmann-La Roche Ltd Profile
5.5.2 F. Hoffmann-La Roche Ltd Main Business
5.5.3 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Ltd Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Ltd Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Blood Glucose Monitoring Products, Services and Solutions
5.6.4 Johnson & Johnson Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Medtronic plc
5.7.1 Medtronic plc Profile
5.7.2 Medtronic plc Main Business
5.7.3 Medtronic plc Blood Glucose Monitoring Products, Services and Solutions
5.7.4 Medtronic plc Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic plc Recent Developments
5.8 Nipro Diagnostics, Inc.
5.8.1 Nipro Diagnostics, Inc. Profile
5.8.2 Nipro Diagnostics, Inc. Main Business
5.8.3 Nipro Diagnostics, Inc. Blood Glucose Monitoring Products, Services and Solutions
5.8.4 Nipro Diagnostics, Inc. Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.8.5 Nipro Diagnostics, Inc. Recent Developments
5.9 Terumo Medical Corporation
5.9.1 Terumo Medical Corporation Profile
5.9.2 Terumo Medical Corporation Main Business
5.9.3 Terumo Medical Corporation Blood Glucose Monitoring Products, Services and Solutions
5.9.4 Terumo Medical Corporation Blood Glucose Monitoring Revenue (US$ Million) & (2018-2023)
5.9.5 Terumo Medical Corporation Recent Developments
6 North America
6.1 North America Blood Glucose Monitoring Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Blood Glucose Monitoring Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Glucose Monitoring Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Glucose Monitoring Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Glucose Monitoring Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Glucose Monitoring Market Dynamics
11.1 Blood Glucose Monitoring Industry Trends
11.2 Blood Glucose Monitoring Market Drivers
11.3 Blood Glucose Monitoring Market Challenges
11.4 Blood Glucose Monitoring Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
